4 Infectious Diseases in Obstetrics and Gynecology Study is described to patients Willing patients sign general informed consent Participants are asked if they are willing to have blood drawn Participants complete questionnaire on demographics and risk factors Unwilling to be tested (participants who do not give informed consent for blood test) Willing to be tested (participants who provide informed consent for blood test) Participants complete questionnaire about barriers to testing Participants have blood drawn Participants receive counseling Participants receive counseling Participants are asked again if they are willing to be tested∗ No Participants complete barriers to testing questionnaire again Participants complete questionnaires on understanding of and satisfaction with counseling The next visit is scheduled on the usual prenatal schedule Participants complete questionnaires on understanding of and satisfaction with counseling Visit 2 is scheduled for 1 week later ∗ If yes, then the path for “willing to be tested” was followed. Figure 1: Study procedures for Visit 1. was of Asian heritage. Approximately two thirds (64%) of participants were employed part or full time, and most women (83%) reported having private or employer-provided health insurance. None of the participants reported a history of genital herpes infection, human immunodeﬁciency virus (HIV) infection, or a rash or viral illness since their last menstrual period. The majority of participants (82% to 92%, depending on the symptom) reported 0 episodes in the past 6 months of genital itching or redness, burning or tingling around genitals, thighs, or buttocks, pain with urination, discharge with urination, or vaginal discharge not associated with other symptoms. Three hundred and four (304) women enrolled in the study and were included in demographic summaries. How- ever, the analyses on willingness to be tested and summaries of questionnaire responses were based on data from 303